The research was conducted to determine the effect of insulin-like growth factor-I (IGF-I) derived from pregnant crossbred mare serum (PMS) on estrous cycle and litter size in mice (Mus musculus). 
Introduction
Insulin-like growth factor-I (IGF-I) is one of bioactive material, a supplementation of IGF-I in maturation and culture medium can stimulate and increase the number of oocyte. Besides, it also can increase the result of in vitro fertilization (IVF) and the amount of some livestock's embryo, such as pigs [1] , cows [2] , and buffaloes [3] , which run into blastocyst. The addition of IGF-I during pig's prenatal follicle culture can enlarge the diameter of follicle. Meanwhile, mRNA insulin-like growth factor receptor-I (IGFR-I) can be increased by adding FSH supplementation as far as the culture and oocyte are able to do meiosis process after maturation [4] . One of the most important aspects in animal reproduction is estrus cycle. Monitoring this cycle plays an important role for fertilization and reproduction as it increases the number of animal population [5] .
Nowadays, many researchers use bioactive to observe its effect toward estrous cycle which purposes to maintain the estrous cycle itself. One of bioactive material that has important role in reproduction is insulin-like growth factor-I (IGF-I). IGF-I is involved in increasing the proliferation of endometrium stromal cell of adult mice [6] . [7] who quoted from many resources stated that IGF-I is a factor which control the follicle and embryo growth. The quality of oocyte and embryo, result of superovulation, totally depend on IGF-I concentration [8] . In vivo, IGF-I concentration in the follicle of cow's superovulation can increase the number of embryo [9] . [10] and [11] stated that the addition of IGF-I into medium culture make the blastocyst percentage and embryo resistance of heat stresses work up. Besides, IGF-I is able to increase the number of lactating Cows pregnancy. Estrous cycle is one of important aspect in animal reproduction. Monitoring to this cycle will improve the success of animal fertilization and reproduction in order to increase the number of animal population [5] .
Adding the insulin-like growth factor-I and insulin-like growth factor binding protein-3 can fasten the puberty of female mice and increase the number of offspring [12] .
When the puberty is about to come, FSH in blood will increase and cause the process of steroidogenesis and folliculogenesis. Steroidogenesis occurs in follicle cell; it is influenced by LH and assisted by IGF-I and IGFBP. This process forms androstenedione and testosterone. They will get into granulose cells from follicle to be converted into estradiol 17β through the process of aromatization which is influenced by FSH and assisted by IGF-I and IGFBP. The increasing of estradiol 17β secretion by granulose cells that is about to get ovulation causes the emergence of lust symptoms. Also, it will stimulate the high rates of LH which cause the ovulation and the emergence of to spermatozoa which will produce more fetus [13] . [14] found that, for some species, IGF-I escalates ovary activity by stimulating granulosa cells, theca cells, and mitogenesis proliferation. IGF-I synergy with gonadotropin in stimulating steroidogenesis [15] . stated that IGF-I concentration during the end of puberty (shortly before the first proestrus) can advance the puberty on mice. Besides, IGF-I in pre-puberty can advance puberty on primates as well.
According to the introduction above, this research is applied on mice by giving insulin-like growth factor-I (IGF-I) pregnant crossbred mare serum (PMS) in which its effect will be observed toward the estrous cycle and the amount of mice litter. This biopotency test is also purposed to comparing the differences between the effect of giving IGF-I PMS and the effect of giving IGF-I recombinant mouse.
Materials and methods
This research was conducted in Obstetric Veterinary Laboratory, Veterinary Reproduc- 
Dose determination
IGF-I dose, based on [17] research, is 10ng/ml which subcutaneously give significant result in enhancing bone resorption. It aims to maintain normal bone mass and to stimulate osteoclastogenesis on mice. On the other hand [18] , added IGF-I dose: 5 ng/ml, 10 ng/ml, and 20 ng/ml on morula growth from oocyte culture of prenatal sheep follicle. This research is using IGF-I PMS and IGF-I recombinant mouse 10 ng/ml, 20 ng/ml, and 40 ng/ml doses for each.
Examined animal treatment
Mice were injected by single dose IGF-I in the first day after seven days adaptation. The PM. This observation is using vaginal smear as the method. Prepare vaginalsmear with
Giemsa staining, then observed by using microscope with 100-400x magnification to determine the mice estrous cycle phases: proestrus, estrus, metestrus, or diestrus [19] .
Serie II was treated, like seri I, by giving the dose as follows: C0: physiological NaCl, T1: 10 ng/ml IGF-I PMS, T2: 20 ng/ml IGF-I PMS, T3: 40 ng/ml IGF-I PMS, T4: 10 ng/ml IGF-I recombinant mouse, T5: 20 ng/ml IGF-I recombinant mouse, and T6: 40 ng/ml IGF-I recombinant mouse per subcutaneous. The injected female mice were gathered with male mice (ratio 5:3) during one lust cycle. The observation would be done until the female mice bear the offsprings in one pregnancy period and they would be counted (± 21 days).
The calculation of lust cycle phase period
The frequency of estrous phase will be converted as the period of estrous cycle [19] .
The function as follows: 
Design of the Study
This research uses Completely Randomized Design (CRD). The conducted data, after
given IGF-I PMS and IGF-I recombinant mouse, would be analyzed by using ANOVA 
Results

The effect of IGF-I PMS and IGF-I recombinant mouse on mice estrous cycle
The result of vaginal smear on mice estrous cycle after given IGF-I PMS will be presented in Table 1 .
Based on the result of mice's vaginal smear in estrous cycle after given IGF-I PMS, it shows that there is difference in this phase. Yet, giving IGF-I PMS does not cause significant difference (p>0.05) from the period of proestrus, metestrus, and diestrus phase in the treatments of T1, T2, and T3IGF-I PMS in the doses of 40 ng/ml and T3 treatment leads estrous phase get longer significantly (p<0.05). The result of mice's vaginal smear in estrous cycle after given IGF-I recombinant mouse is presented in Table 3 . Estrous is a transition phase from proestrus to metestrus. This phase is marked by the receipt male animals by females to do copulation. The period of this phase will be longer after given IGF-I PMS, while there is no significant difference (p>0.05) by giving Diestrus is the phase after metestrus when the objects were given IGF-I PMS in the treatments of T1, T2, and T3, the change of phase was longer yet there was no significant differences between the treatment (p>0.05). Meanwhile, giving IGF-I recombinant mouse with the treatments of T4 and T6toward the objects showed that diestrus phase period is significantly longer (p<0.05) comparing to C0 ( Table 2 ). The change of diestrus phase is longer because of the high rates of progesterone level in the blood vessels. This progesterone level is produced by corpus luteum after ovulation. 
The effect of IGF-I PMS and IGF-I recombinant mouse toward the amount of mice
The result of giving IGF-I PMS and IGF-I recombinant mouse on female mice in this research subcutaneously showed good response toward the amount of mice litter.
Monitoring result of mice litter will be presented in Table 4 .
This research used ANOVA to analyze statistically toward the amount of mice litter by giving them IGF-I pregnant crossbreed mare serum rather than IGF-I recombinant mouse subcutaneously. The result is not significantly different (p<0.05) and from this result it can be seen that giving IGF-I PMS subcutaneously has the same level of efficiency with IGF-I recombinant mouse toward the amount of mice litter.
The doses that are given in this research are various. With C0 which contains 0.1 ml of physiological NaCl, the number of mice litter is fewer than if they are given IGF-I pregnant crossbreed mare serum and IGF-I recombinant mouse. By giving IGF-I PMS with doses of T1 10 ng/ml, T2 20 ng/ml, and T3 40 ng/ml consecutively, the obtained it can be seen that the number of mice in T3 is significantly different from group ofC0.
Meanwhile, in the groups of T1, T2, T4, T5, and T6 are not significantly different from C0 although there is an enhancement of mice litter number here. This is due to some factors, such as the condition of female mice hormones, how the substance given, and the environmental factor. Moreover, the comparison result shows that there is no significant difference between IGF-I pregnant crossbreed mare serum and IGF-I recombinant mouse.
Discussion
The effect of IGF-I PMS and IGF-I recombinant mouse on mice estrous cycle
Estrous cycle is the sexual cycle which is happened in female animal. It is divided into two phases: follicular and luteal. Follicular is a phase where follicle develops until the outbreak of de Graaf follicle (ovulation). This phase causes proestrus and estrous symptoms. On the other hand, luteal is a phase after ovulation in which it is following the period of progesterone secretion and the phase of corpus luteum formation.
This phase causes metestrus and diestrus symptoms [22] . This shows a connection between IGF-I PMS and hormonal condition on female mice, and its effect on estrous cycle.
Estrus phase, estrogen and LH reach the highest rate, while it reaches the lowest rate in diestrus phase [23] . Besides, the follicle size will be getting bigger. The bigger follicle size, the estrogen synthesis will increase as well [24] . Because the estrogen hormone increases, the period of estrous phase will be longer. According to [25] , the long period of estrous phase will be important implication for mice reproduction because they have long mating. Moreover, long extension phase of estrous if they are given IGF-I PMS with T3 comparing to C0, it would be more benefit and has significant potential in terms of fertilization.
Metestrus phase according to [26] , the high rates of estrogen causes vascularization from endometrium. Maximum vascularization occured in the end of the phase.
It dropped down causing blood vessels are back to former position and it could be seen there are many ruptured capillaries thus leukocytes are found in vaginal smear.
Diestrus is the phase after metestrus. This phase lasted 60-70 hours [27] .
The effect of IGF-I PMS and IGF-I recombinant mouse toward the amount of mice
There are some factors that affect a variation number of mice litter in every treatment, such as the object, the given doses, the given IGF-I pregnant crossbreed mare serum and IGF-I recombinant mouse, and injection time. The animals that are used to be an object is really influential for research, especially for the hegemonity. The level of IGF-I concentration on blood vessels of cattles which have not entered puberty will decrease and cause a delay of puberty. This is related to the lowering number of follicle growth and it can undermine the ability of ovary in producing estradiol, so that it will postpone LH stimulation [32] . Stated of [33] that adding IGF-I toward heifer is signed as the possibility of puberty occurence when somatic grows as With the help of enzyme (ovulatory lytic enzym), follicle will rupture and ovulation happens.
Conclusion
The addition of insulin-like growth factor-I(IGF-I) derived from pregnant crossbred mare serum (PMS) can extend estrous phase in estrous cycle and increase the amount of mice litter sizes (Mus musculus). Giving IGF-I PMS will affect as well as giving IGF-I recombinant mouse toward estrous cycle (proestrus, estrus, metestrus, and diestrus phase) and the amount of mice litter (Mus musculus). IGF-I pregnant crossbred mare serum and IGF-I recombinant mouse are interchangeable or just as good.
